Hani hamed dessoki schizophrenia

138 views
91 views

Published on

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
138
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Hani hamed dessoki schizophrenia

  1. 1. Schizophrenia: new updates Dr. Hani Hamed Dessoki, M.D.Psychiatry Prof. Psychiatry Chairman of Psychiatry Department Beni Suef University Supervisor of Psychiatry Department El-Fayoum University APA member
  2. 2. Evidence-Based Psychotherapy for Schizophrenia 2011 Update  any patients with schizophrenia have psychological distress and receive some form of psychotherapy.  Several different psychotherapeutic approaches for schizophrenia have been developed and studied.  Of these approaches, cognitive behavior therapy (CBT) has the strongest evidence base and has shown benefit for symptom reduction in outpatients with residual symptoms.  In addition to CBT, other approaches include compliance therapy, personal therapy, acceptance and commitment therapy, and supportive therapy. Faith B. Dickerson; Anthony F. Lehman, FOCUS 2012;10:217-225.
  3. 3. Evidence-Based Psychotherapy for Schizophrenia 2011 Update  Although usually studied as distinct approaches, these therapies overlap with each other in their therapeutic elements.  Psychotherapy for schizophrenia continues to evolve with the recent advent of such approaches as meta-cognitive therapy, narrative therapies, and mindfulness therapy.   Future research may also consider three different goals of psychotherapy in this patient population: to provide emotional support, to enhance functional recovery, and to alter the underlying illness process. Faith B. Dickerson; Anthony F. Lehman, FOCUS 2012;10:217-225.
  4. 4. Schizophrenia and autoimmune diseases New data show that individuals with schizophrenia are at increased risk of developing autoimmune diseases, according to a study reported yesterday in AJP in Advance. Michael Benros
  5. 5. New Data The increased risk of subsequent autoimmune diseases in individuals with schizophrenia may involve neuropsychiatric manifestations from the undiagnosed autoimmune disease, medical treatment or lifestyle associated with schizophrenia, or common etiological mechanisms, such as infections and shared genetic factors.
  6. 6. New Data  An increased risk of schizophrenia in those with autoimmune diseases, but that theirs is the first study to investigate the link between schizophrenia and subsequent development of an autoimmune disease "and to consider the effect of infections, a possible risk factor for both schizophrenia and autoimmune diseases."
  7. 7. Immune System Protein Could Give Clue to Late-Onset Schizophrenia An immune system component called Creactive protein appears to be associated with late-onset schizophrenia, suggesting that immune-system-provoked inflammation contributes to the illness. Psychiatric News, Clinical and Research News,October 10, 2013
  8. 8. Sodium Benzoate May Improve Symptoms, Cognition in Schizophrenia, Study Suggests Sodium benzoate—commonly used as a food preservative—appears to improve symptoms and cognition in schizophrenia when used as an adjunct to antipsychotic medication therapy.
  9. 9. Mechanism Benzoate blocks the metabolism of d-amino acids, which in turn enhances the function of the NMDA receptor in the brain; NMDA is believed to be vital to cognition, a crucial symptom domain of schizophrenia. “The preliminary results show promise for damino acid oxidase inhibition as a novel approach for new drug development for schizophrenia,” the authors said.

×